Skip to main content

Thursday's ETF Winners & Losers

Asia-related funds were among Thursday's top performers.

Exchange-traded funds tracking Asian markets were among the best performers Thursday, as indices in Japan, China, Hong Kong and Indonesia rose overnight.

Japan's Nikkei 225 and Hong Kong's Hang Seng both soared 2.4% overnight, China's CSI 300 Index gained 1.2%, and Indonesia's Jakarta Index added 0.8%.

The

PowerShares Golden Dragon Halter USX China

(PGJ) - Get Free Report

rose 63 cents, or 1.9%, to $33.42. The

iShares FTSE/Xinhua China 25 Index

(FXI) - Get Free Report

was higher by $3.03, or 1.7%, to $179.09. The

iShares MSCI Japan Index

(EWJ) - Get Free Report

was up 23 cents, or 1.6%, to $14.26. The

SPDR S&P China

(GXC) - Get Free Report

was adding $1.56, or 1.7%, to $93.85.

Bundled securities following the financial sector were also higher, as enthusiasm for

Bear Stearns

(BSC)

carried over from the previous session. Last time out, Bear Stearns fueled a rally in financials after rumors swirled that billionaire investor Warren Buffett was interested in buying a stake in the investment bank.

The

WisdomTree International Financial

(DRF)

was gaining 57 cents, or 2%, to $28.98. The

iShares Dow Jones U.S. Broker-Dealers

(IAI) - Get Free Report

was up 38 cents, or 0.7%, to $52.06. The

Ultra Financials ProShares

(UYG) - Get Free Report

was rising 12 cents, or 0.2%, to $57.09. The

KBW Regional Banking

(KRE) - Get Free Report

added 7 cents, or 0.2%, to $44.50.

Once again, the

United States Natural Gas

(UNG) - Get Free Report

ETF was the worst decliner of the session, as natural gas futures declined after a bearish report on natural gas inventories. Natural gas fell 21 cents to $6.83 per million British thermal units. The ETF was lower by $1.33, or 3.4%, to $37.95.

Biotech-related ETFs were also among the worst performers. Shares of

Biogen Idec

(BIIB) - Get Free Report

,

CV Therapeutics

undefined

and

Human Genome Sciences

(HGSI)

all were sliding.

The

PowerShares Dynamic Biotech & Genome

(PBE) - Get Free Report

was off 35 cents, or 1.8%, to $19.40. The

First Trust Amex Biotechnology Index

(FBT) - Get Free Report

lost 28 cents, or 1.1%, to $25.57. The

SPDR S&P Biotech

(XBI) - Get Free Report

was down 32 cents, or 0.6%, to $58.05.